Merck EPS Basic from Extraordinaries (Quarterly) Analysis

Merck & Co., Inc. (MRK)

107.68 -1.51 (-1.38%) USD | NYSE | Jan 13, 09:55

View EPS Basic from Extraordinaries (Quarterly) for MRK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Cidara Therapeutics, Inc.	--
Moderna, Inc.	--